Harry Björkbacka

6.3k citations

93 papers · 4.5k indexed · 1 hit paper · h-index 38

Impact in

Immunology top 0.5%
- Atherosclerosis and Cardiovascular Diseases
- Immune Response and Inflammation
- T-cell and B-cell Immunology
- Immune cells in cancer
- Immune Cell Function and Interaction
Immunology and Allergy top 2%
- Cell Adhesion Molecules Research

Papers in

Immunology 70
- Atherosclerosis and Cardiovascular Diseases 58
- T-cell and B-cell Immunology 21
- Immune Cell Function and Interaction 12
- IL-33, ST2, and ILC Pathways 8
Immunology and Allergy 12
- Cell Adhesion Molecules Research 12

Co-authors: Jan Nilsson Gunilla Nordin Fredrikson Irena Ljungcrantz Douglas T. Golenbock Bo Hedblad Maria Wigren Linda Andersson Eva Bengtsson
Journals: Journal of Internal Medicine (10 papers)Atherosclerosis (9 papers)Arteriosclerosis Thrombosis and Vascular Biology (9 papers)Cardiovascular Research (5 papers)Stroke (4 papers)
Partner nations: Sweden United States Germany

In The Last Decade

Harry Björkbacka

93 papers receiving 4.4k citations

Hit Papers

align trajectories log scale

Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways 2004 · 503 citations

Peers

Countries citing papers authored by Harry Björkbacka

Since Specialization

Citations

This map shows the geographic impact of Harry Björkbacka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Björkbacka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Björkbacka more than expected).

Fields of papers citing papers by Harry Björkbacka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Björkbacka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Björkbacka. The network helps show where Harry Björkbacka may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Harry Björkbacka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Harry Björkbacka Line = papers co-authored together Harry Björkbacka links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Invariant natural killer T cells and incidence of first-time coronary events: a nested case-control study European Heart Journal Open ·Lukas Tomas, Н Б Кухтина, Wiaam Badn, Linda Andersson, Jan Nilsson, Alexandru Șchiopu, Daniel Engelbertsen, Isabel Gonçalves, Eva Bengtsson, Harry Björkbacka	2023	1
2	Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction Critical Care ·Rutul Mashruwala, Praveen Papareddy, Henrik Andersson, Л.С. Кольцова, Ravi K. V. Bhongir, Irena Ljungcrantz, Daniel Engelbertsen, Harry Björkbacka, Jan Nilsson, Adrian Manea, Heiko Herwald, Marisol Ruiz‐Meana, Antonio Rodríguez‐Sinovas, Michelle S. Chew, Alexandru Șchiopu	2023	39
3	Monoclonal Autoantibody Against a Cryptic Epitope on Tissue-Adherent Low-Density Lipoprotein for Molecular Imaging in Atherosclerosis JACC. Cardiovascular imaging ·Ramzi Khamis, Adam Hartley, Stefan Pleszczynski, Jiyun Oh, Tengizi Toriashvili, Chiari Kojima, Shang‐Hung Chang, Joseph J. Boyle, Jason L. Johnson, Harry Björkbacka, Liang Guo, Aloke V. Finn, Renu Virmani, Jan Nilsson, Dorian O. Haskard	2022	2
4	LAG3 Regulates T Cell Activation and Plaque Infiltration in Atherosclerotic Mice JACC CardioOncology ·Л.С. Кольцова, Eva Kritikou, Н Б Кухтина, Jan Nilsson, Harry Björkbacka, Andrew H. Lichtman, Annabelle Rodríguez, Daniel Engelbertsen	2022	19
5	High levels of autoantibodies against apoB100 p210 are associated with lower incidence of atrial fibrillation in women Journal of Internal Medicine ·Kari Anne Sveen, Gustav Smith, Harry Björkbacka, Marju Orho‐Melander, Gunnar Engström, Isabel Gonçalves, Olle Melander, Jan Nilsson, Eva Bengtsson	2021	5
6	B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice Vascular Pharmacology ·Sara Rattik, S L Li, Ingrid Yao Mattisson, Irena Ljungcrantz, بهرام سیاوش پور, Harry Björkbacka, Ismari Perini Furlaneto, Michael Lebens, Jan Holmgren, Jan Nilsson, Maria Wigren, Gunilla Nordin Fredrikson	2018	6
7	High Levels of (Un)Switched Memory B Cells Are Associated With Better Outcome in Patients With Advanced Atherosclerotic Disease Journal of the American Heart Association ·L. Shykova, Signaux Jc, Aisha Gohar, Yuririana Pérez González, Sander M. van de Weg, Crystel M. Gijsberts, Saskia Haitjema, Harry Björkbacka, Gunilla Nordin Fredrikson, Gert J. de Borst, Hester M. den Ruijter, Gerard Pasterkamp, Christoph J. Binder, Imo E. Hoefer, Saskia C.A. de Jager	2017	31
8	IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout mice Atherosclerosis ·Sara Rattik, Karin Hultman, Uwe Rauch, Ingrid Söderberg, بهرام سیاوش پور, Irena Ljungcrantz, Anna Hultgårdh‐Nilsson, Maria Wigren, Harry Björkbacka, Gunilla Nordin Fredrikson, Jan Nilsson	2015	41
9	Induction of T helper 2 responses against human apolipoprotein B100 does not affect atherosclerosis in ApoE−/− mice Cardiovascular Research ·Daniel Engelbertsen, Sara Rattik, Haruko Yoshida Kantaro Fujioka, Harry Björkbacka, Eva Bengtsson, Jan Nilsson	2014	18
10	A high quality diet is associated with reduced systemic inflammation in middle-aged individuals Atherosclerosis ·Joana Alves Dias, Elisabet Wirfält, Isabel Drake, Bo Gullberg, Bo Hedblad, Margaretha Persson, Gunnar Engström, Jan Nilsson, Alexandru Șchiopu, Gunilla Nordin Fredrikson, Harry Björkbacka	2014	44
11	Is Toll-like receptor responsiveness a marker and predictor of coronary artery disease? Atherosclerosis ·Harry Björkbacka	2013	4
12	TAP1-Deficiency Does Not Alter Atherosclerosis Development in Apoe−/− Mice PLoS ONE ·Daniel Kolbus, Irena Ljungcrantz, Ingrid Söderberg, Ragnar Alm, Harry Björkbacka, Jan Nilsson, Gunilla Nordin Fredrikson	2012	34
13	Rip2 Deficiency Leads to Increased Atherosclerosis Despite Decreased Inflammation Circulation Research ·Malin Levin, Pernilla Jirholt, Joel Parra-Díaz, Maria E. Johansson, Anna M. Lundberg, Maria Trajkovska, Marcus Ståhlman, Per Fogelstrand, Mikael Brisslert, Linda Fogelstrand, Zhong-qun Yan, Göran K. Hansson, Harry Björkbacka, Sven‐Olof Olofsson, Jan Borén	2011	33
14	The vascular repair process after injury of the carotid artery is regulated by IL-1RI and MyD88 signalling Cardiovascular Research ·Amit Saxena, Uwe Rauch, Kris Berg, Ludwig Beethoven J. Noya, L Hollender, 姜志茹, Maria F. Gomez, Anna Hultgårdh‐Nilsson, Jan Nilsson, Harry Björkbacka	2011	25
15	Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study Atherosclerosis ·Margaretha Persson, Gunnar Engström, Harry Björkbacka, B. Hedblad	2011	74
16	FcγRIIB Inhibits the Development of Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice The Journal of Immunology ·Ming Zhao, Maria Wigren, Pontus Dunér, Daniel Kolbus, Katarina Olofsson, Harry Björkbacka, Jan Nilsson, Gunilla Nordin Fredrikson	2010	42
17	Immunization with cationized BSA inhibits progression of disease in ApoBec-1/LDL receptor deficient mice with manifest atherosclerosis Immunobiology ·Daniel Kolbus, Maria Wigren, Irena Ljungcrantz, Ingrid Söderberg, Ragnar Alm, Harry Björkbacka, Jan Nilsson, Gunilla Nordin Fredrikson	2010	9
18	Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide Journal of Lipid Research ·Ulf Diczfalusy, Katarina Olofsson, Annelie Carlsson, Mei Gong, Douglas T. Golenbock, Olav Rooyackers, Urban Fläring, Harry Björkbacka	2009	160
19	Multiple roles of Toll-like receptor signaling in atherosclerosis Current Opinion in Lipidology ·Harry Björkbacka	2006	79
20	Possible Roles for His 208 in the Active-Site Region of Chloroplast Carbonic Anhydrase fromPisum sativum Archives of Biochemistry and Biophysics ·Harry Björkbacka, Inga‐Maj Johansson, Cecilia Forsman	1999	15

About Harry Björkbacka

Harry Björkbacka is a scholar working on Immunology, Immunology and Allergy, Cancer Research, Rheumatology and Epidemiology, having authored 93 papers that have together received 4.5k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (58 papers), T-cell and B-cell Immunology (21 papers), Adipokines, Inflammation, and Metabolic Diseases (14 papers), Immune Cell Function and Interaction (12 papers), Cell Adhesion Molecules Research (12 papers), Protease and Inhibitor Mechanisms (10 papers), Systemic Lupus Erythematosus Research (8 papers) and IL-33, ST2, and ILC Pathways (8 papers). The work is most often cited by research in Immunology (2.5k citations), Immunology and Allergy (283 citations), Cancer Research (461 citations), Epidemiology (929 citations) and Rheumatology (378 citations). Harry Björkbacka has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Jan Nilsson, Gunilla Nordin Fredrikson, Irena Ljungcrantz, Douglas T. Golenbock, Bo Hedblad, Maria Wigren, Linda Andersson, Eva Bengtsson, Mason W. Freeman and Isabel Gonçalves. Their work appears in journals such as Journal of Internal Medicine, Atherosclerosis, Arteriosclerosis Thrombosis and Vascular Biology, Cardiovascular Research and Stroke.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact